Talymed® advanced sterile wound matrix is composed of shortened fibers of poly-N-acetyl glucosamine (pGlcNAc), isolated from microalgae.
In a randomized, multi-center clinical trial, significantly more (86.4% vs. 45%) VLU patients experienced complete wound healing in 20 weeks when receiving standard of care (multilayer compression) plus Talymed vs. standard of care alone.1
To learn more about Talymed's superior efficacy, contact us today.
Indications for Use:
Talymed® is indicated for the management of wounds including: diabetic ulcers, venous ulcers, pressure wounds, ulcers caused by mixed vascular etiologies, full thickness and partial thickness wounds, second degree burns, surgical wounds-donor sites/grafts, post-mohs surgery, post-laser surgery, and other bleeding surface wounds, abrasions, lacerations, traumatic wounds healing by secondary intention, chronic vascular ulcers, dehisced surgical wounds.
PRECAUTIONS: There are no known contraindications to the use of Talymed®.
CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician or other licensed practitioner.
Manufactured by Marine Polymer Technologies, Inc. For instructions for use or additional product information, please contact us.
Talymed® - Ordering Information:
|Item #||Description||Matrix Size|
|400-20||Talymed 5 cm x 5 cm||25 sq cm|